Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo khoa học: "Target splitting in radiation therapy for lung cancer: further developments and exemplary treatment plans"
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: "Target splitting in radiation therapy for lung cancer: further developments and exemplary treatment plans. | Radiation Oncology BioMed Central Research Target splitting in radiation therapy for lung cancer further developments and exemplary treatment plans Karl Wurstbauer Heinz Deutschmann Peter Kopp Florian Merz Helmut Scholler and Felix Sedlmayer Open Access Address Department of Radiation Oncology and radART - Institute for Research and Development on Advanced Radiation Technologies at the Paracelsus Medical University Salzburg Austria Email Karl Wurstbauer - k.wurstbauer@salk.at Heinz Deutschmann - h.deutschmann@salk.at Peter Kopp - p.kopp@salk.at Florian Merz - f.merz@salk.at Helmut Scholler - h.schoeller@salk.at Felix Sedlmayer - f.sedlmayer@salk.at Corresponding author Published 14 August 2009 Received 20 May 2009 RadiationOncology 2009 4 30 doi l0.ll86 l748-7l7X-4-30 Accepted I4 August 2009 This article is available from http www.ro-journal.cOm content 4 l 30 2009 Wurstbauer et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Reporting further developments evolved since the first report about this conformal technique. Methods Technical progress focused on optimization of the quality assurance QA program especially regarding the required work input and on optimization of beam arrangements. Results Besides performing the regular QA program additional time consuming dosimetric measurements and verifications no longer have to be accomplished. Class solutions of treatment plans for six patients with non-resected non-small cell lung cancer in locally advanced stages are presented. Target configurations comprise one central and five peripheral tumor sites with different topographic positions to hilus and mediastinum. The mean dose to the primary tumor is 8l 9 Gy range 79 2-90 0 Gy to macroscopically involved